• Newsletters
  • Gift Membership
Logo Logo
Take Scroll With You Download the app to read our award-winning journalism on the go and stay up-to-date with our notifications.
Get the app Get the app
ANDROID iOS
  • Home
  • Common Ground
  • The India Fix
  • Eco India
  • The Latest
  • The Reel
  • Magazine
  • Video
  • Trending
    • After demolitions in Delhi’s Madrasi Camp, Tamil Nadu offers support to families
    • UK’s new rules for international students will worsen university finances
    • Why RSS outfit members are at centre of a Rs 14-crore scam at ICHR
    • In Hyderabad, the international style of art deco reveals itself in homes, with personal touches
    • Talented Indians thought they could make Germany home, but many want to move on now
    • ‘I was astonished’: Valmik Thapar (1952–2025) on spotting one of his beloved tigers in the wild
    • Long shunned as too explicit, an Indian music genre is rising from the margins
    • Probing link between Savarkar, Godse families not needed to decide defamation case: Pune court
    • Nature, who needs it? A writing adventure with Ranjit Hoskote at the Himalayan Writing Retreat
    • Fiction pick: An elderly Bengali couple cannot decide what to feed their son-in-law on Jamai Shashti
    • This new cookbook has compiled heirloom recipes from every corner of India
    • Jammu & Kashmir: Ramban downpour devastation was made worse by construction
  • Sections
    • Politics
    • Culture
    • India
    • World
    • Film and TV
    • Music
    • Books and Ideas
    • Business and Economy
    • Science and Technology
    • In Pictures
    • Announcements
    • Bookshop
    • The Field
    • Pulse
    • Elections 2024

Drug Controller General of India

  • Six years, ‘lost’ documents, litigation fatigue: The hopelessness of public health advocacy in India

    Six years, ‘lost’ documents, litigation fatigue: The hopelessness of public health advocacy in India

    Dinesh Thakur
    · Jan 30, 2025 · 09:00 am
  • Bharat Biotech submits phase 3 trial data of Covaxin, expert panel to meet today to discuss results

    Bharat Biotech submits phase 3 trial data of Covaxin, expert panel to meet today to discuss results

    Scroll Staff
    · Jun 22, 2021 · 12:54 pm
  • Coronavirus vaccine: ‘We will probably have something in hand in new year,’ says top official

    Coronavirus vaccine: ‘We will probably have something in hand in new year,’ says top official

    Scroll Staff
    · Dec 31, 2020 · 03:30 pm
  • Coronavirus: Drug controller tells Serum Institute to stop recruiting for further vaccine trials

    Coronavirus: Drug controller tells Serum Institute to stop recruiting for further vaccine trials

    Scroll Staff
    · Sep 12, 2020 · 08:59 am
  • Coronavirus: Glenmark defends pricing of its favipiravir drug, calls it ‘effective treatment option’

    Coronavirus: Glenmark defends pricing of its favipiravir drug, calls it ‘effective treatment option’

    Scroll Staff
    · Jul 21, 2020 · 02:32 pm
  • Drug controller clears psoriasis injection for restricted emergency use on Covid-19 patients

    Drug controller clears psoriasis injection for restricted emergency use on Covid-19 patients

    Scroll Staff
    · Jul 11, 2020 · 10:19 am
  • Slow and opaque decisions during Covid-19 crisis put the spotlight on India’s drug regulator

    Slow and opaque decisions during Covid-19 crisis put the spotlight on India’s drug regulator

    Arunabh Saikia
    · Jun 22, 2020 · 09:00 am
  • Coronavirus: Pharma firm Hetero gets drug controller’s nod to produce, market remdesivir

    Coronavirus: Pharma firm Hetero gets drug controller’s nod to produce, market remdesivir

    Scroll Staff
    · Jun 21, 2020 · 06:24 pm
  • E-pharmacies: Doctors fear rise in self-medication and abuse unless online drug sales are checked

    E-pharmacies: Doctors fear rise in self-medication and abuse unless online drug sales are checked

    Priyanka Vora
    · Feb 10, 2017 · 01:30 pm